US Map / Michigan
State MI

Clinical Trials in Michigan

Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 351 actively recruiting studies with Michigan sites out of 351 registered in total. The busiest research areas in Michigan are Breast Cancer, Ovarian Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include University of Michigan, National Cancer Institute (NCI), AstraZeneca. By stage, Michigan trials break down as Phase 1 (64), Phase 2 (108), Phase 3 (88), Phase 4 (12).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
351
Recruiting Now
351
← Back to US Map
Top Conditions in Michigan
Breast Cancer (14)Ovarian Cancer (8)Advanced Solid Tumor (6)Prostate Cancer (6)Non-Small Cell Lung Cancer (6)Endometrial Cancer (6)Healthy (5)Advanced Solid Tumors (5)Solid Tumors (5)Metastatic Breast Cancer (4)Solid Tumor (4)Pancreatic Ductal Adenocarcinoma (4)

Frequently Asked Questions — Clinical Trials in Michigan

How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 351 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 351. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Ovarian Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Michigan

NCT07096674 Phase 2
Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopa...
Condition
Narcolepsy Type 1
Enrollment
90 pts
Location
United States, Canada, Italy
Sponsor
Centessa Pharmaceuticals (UK)
View Trial →
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05564390 Phase 2
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatmen...
Condition
Acute Myeloid Leukemia
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06915168 N/A
Recruiting
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patient...
Condition
Breast Carcinoma
Enrollment
20 pts
Location
United States
Sponsor
University of Michigan Rogel C
View Trial →
NCT06819891 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (...
Condition
Moderately to Severely Active Crohns Disease
Enrollment
425 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT06417762 N/A
Recruiting
Dime La VerDAD: Verify, Debunk, and Disseminate
Condition
Influenza
Enrollment
1,400 pts
Location
United States
Sponsor
University of Chicago
View Trial →
NCT07223697 Phase 2
Recruiting
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (R...
Condition
Atopic Dermatitis
Enrollment
120 pts
Location
United States, Brazil, Canada
Sponsor
Hoffmann-La Roche
View Trial →
NCT06929923 N/A
Recruiting
Pro-2-Cool Pivotal Trial II
Condition
Concussion, Mild
Enrollment
66 pts
Location
United States
Sponsor
TecTraum Inc.
View Trial →
NCT06269510 N/A
Recruiting
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patient...
Condition
Alcohol-related Liver Disease
Enrollment
268 pts
Location
United States
Sponsor
Henry Ford Health System
View Trial →
NCT06641310 N/A
Recruiting
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
Condition
Familial Adenomatous Polyposis
Enrollment
32 pts
Location
United States
Sponsor
University of Michigan Rogel C
View Trial →
NCT06906627 N/A
Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (...
Condition
Chronic Kidney Disease(CKD)
Enrollment
750 pts
Location
United States
Sponsor
Duke University
View Trial →
NCT06149780 N/A
Recruiting
Fractionated 1927-nm Non Ablative Thulium Laser in Treating Post Inflammatory Hy...
Condition
Healthy
Enrollment
15 pts
Location
United States
Sponsor
Henry Ford Health System
View Trial →
NCT06994442 Phase 3
Recruiting
Optimizing Pain Treatment in Children On Mechanical Ventilation
Condition
Mechanical Ventilation
Enrollment
644 pts
Location
United States
Sponsor
Weill Medical College of Corne
View Trial →
NCT02432560 N/A
Recruiting
Safety and Durability of Sirolimus for Treatment of LAM
Condition
Lymphangioleiomyomatosis
Enrollment
600 pts
Location
United States
Sponsor
University of Cincinnati
View Trial →
NCT06841796 N/A
Recruiting
The YMCA Healthy Lifestyle Program for Prediabetes
Condition
PreDiabetes
Enrollment
84 pts
Location
United States
Sponsor
Young Men's Christian Associat
View Trial →
NCT02922894 Phase 4
Recruiting
Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury
Condition
Sleep Apnea
Enrollment
100 pts
Location
United States
Sponsor
John D. Dingell VA Medical Cen
View Trial →
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT04121780 Phase 2
Recruiting
Growth Hormone Replacement Therapy for Retried Professional Football Players
Condition
TBI (Traumatic Brain Injury)
Enrollment
42 pts
Location
United States
Sponsor
Center for Neurological Studie
View Trial →
NCT06174727 N/A
Recruiting
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
Condition
Intracranial Aneurysm
Enrollment
5,000 pts
Location
United States, Canada
Sponsor
Montefiore Medical Center
View Trial →
NCT06712654 Phase 2
Recruiting
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in...
Condition
Hyperphosphatemia
Enrollment
168 pts
Location
United States, China
Sponsor
R1 Therapeutics
View Trial →
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Car...
Condition
Clear Cell Renal Cell Carcinoma
Enrollment
362 pts
Location
United States, Australia, South Korea
Sponsor
Arcus Biosciences, Inc.
View Trial →
NCT06883305 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participa...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
990 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
View Trial →
NCT05735080 Phase 1, Phase 2
Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-3...
Condition
Breast Cancer
Enrollment
150 pts
Location
United States, Australia
Sponsor
Incyclix Bio
View Trial →
NCT05988931 N/A
Recruiting
Technology Interventions for Youth Alcohol Use
Condition
Alcohol Drinking
Enrollment
1,400 pts
Location
United States
Sponsor
University of Michigan
View Trial →
Page 5 of 15 — 351 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology